ATHENA MOON: Open Payments
NPI 1528511169 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 40 payments from 10 companies in 2025. Trend: 2023 $388 · 2024 $808 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $378 |
| Novo Nordisk Inc | 14 | $233 |
| PFIZER INC. | 6 | $113 |
| Lilly USA, LLC | 4 | $83 |
| ABBVIE INC. | 3 | $53 |
| Exact Sciences Corporation | 2 | $30 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: FARXIGA, Rybelsus, AIRSUPRA, ELIQUIS, MOUNJARO, Ozempic, UBRELVY, BREZTRI.
Industry payments across TX — which companies pay providers there.
